Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines
2007

Swainsonine Reduces 5-Fluorouracil Tolerance in Colorectal Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Hamaguchi Jun, Nakagawa Hiroaki, Takahashi Masato, Kudo Takeaki, Kamiyama Naoya, Sun Bailong, Oshima Takahiro, Sato Yuji, Deguchi Kisaburo, Todo Satoru, Nishimura Shin-Ichiro

Primary Institution: Hokkaido University

Hypothesis

Can swainsonine reduce 5-FU tolerance in colorectal cancer cell lines?

Conclusion

Swainsonine may enhance chemotherapy effectiveness by reducing drug resistance in colorectal cancer cells.

Supporting Evidence

  • Swainsonine reduced the IC-50 values of resistant cell lines against 5-FU.
  • Different mechanisms of 5-FU resistance were observed in the established cell lines.
  • Swainsonine treatment did not affect the sensitivity of the parental cell line to 5-FU.

Takeaway

Swainsonine helps cancer cells respond better to a common drug called 5-FU, making it easier to treat colorectal cancer.

Methodology

The study established various 5-FU resistant cell lines and analyzed the effects of swainsonine on drug sensitivity and N-glycan profiles.

Digital Object Identifier (DOI)

10.1186/1476-4598-6-58

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication